SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-000762
Filing Date
2024-01-08
Accepted
2024-01-08 07:04:40
Documents
49
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fhtx-20240108.htm   iXBRL 8-K 34283
2 EX-99.1 exhibit991pressrelease1-8x.htm EX-99.1 20447
3 EX-99.2 exhibit992investorpresen.htm EX-99.2 34752
7 GRAPHIC exhibit992investorpresen001.jpg GRAPHIC 73778
8 GRAPHIC exhibit992investorpresen002.jpg GRAPHIC 263745
9 GRAPHIC exhibit992investorpresen003.jpg GRAPHIC 96434
10 GRAPHIC exhibit992investorpresen004.jpg GRAPHIC 127112
11 GRAPHIC exhibit992investorpresen005.jpg GRAPHIC 100009
12 GRAPHIC exhibit992investorpresen006.jpg GRAPHIC 90573
13 GRAPHIC exhibit992investorpresen007.jpg GRAPHIC 64728
14 GRAPHIC exhibit992investorpresen008.jpg GRAPHIC 120048
15 GRAPHIC exhibit992investorpresen009.jpg GRAPHIC 117291
16 GRAPHIC exhibit992investorpresen010.jpg GRAPHIC 110002
17 GRAPHIC exhibit992investorpresen011.jpg GRAPHIC 121993
18 GRAPHIC exhibit992investorpresen012.jpg GRAPHIC 128342
19 GRAPHIC exhibit992investorpresen013.jpg GRAPHIC 115637
20 GRAPHIC exhibit992investorpresen014.jpg GRAPHIC 134829
21 GRAPHIC exhibit992investorpresen015.jpg GRAPHIC 60748
22 GRAPHIC exhibit992investorpresen016.jpg GRAPHIC 128866
23 GRAPHIC exhibit992investorpresen017.jpg GRAPHIC 113434
24 GRAPHIC exhibit992investorpresen018.jpg GRAPHIC 88784
25 GRAPHIC exhibit992investorpresen019.jpg GRAPHIC 66078
26 GRAPHIC exhibit992investorpresen020.jpg GRAPHIC 88013
27 GRAPHIC exhibit992investorpresen021.jpg GRAPHIC 122219
28 GRAPHIC exhibit992investorpresen022.jpg GRAPHIC 81857
29 GRAPHIC exhibit992investorpresen023.jpg GRAPHIC 62505
30 GRAPHIC exhibit992investorpresen024.jpg GRAPHIC 86597
31 GRAPHIC exhibit992investorpresen025.jpg GRAPHIC 115789
32 GRAPHIC exhibit992investorpresen026.jpg GRAPHIC 82710
33 GRAPHIC exhibit992investorpresen027.jpg GRAPHIC 76167
34 GRAPHIC exhibit992investorpresen028.jpg GRAPHIC 63375
35 GRAPHIC exhibit992investorpresen029.jpg GRAPHIC 94368
36 GRAPHIC exhibit992investorpresen030.jpg GRAPHIC 103479
37 GRAPHIC exhibit992investorpresen031.jpg GRAPHIC 58089
38 GRAPHIC exhibit992investorpresen032.jpg GRAPHIC 106346
39 GRAPHIC exhibit992investorpresen033.jpg GRAPHIC 114663
40 GRAPHIC exhibit992investorpresen034.jpg GRAPHIC 90639
41 GRAPHIC exhibit992investorpresen035.jpg GRAPHIC 96496
  Complete submission text file 0001628280-24-000762.txt   5152993

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20240108.xsd EX-101.SCH 1907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20240108_lab.xml EX-101.LAB 24846
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20240108_pre.xml EX-101.PRE 13047
43 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20240108_htm.xml XML 2829
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 24518291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)